Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthay

Showing results (1191-1200 of 1,339) with videos related to

Pageof 134
Sort By:
Pediatric Blood & Cancer|April 7, 2017
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSteven G DuBois, Rajen Mody, Arlene Naranjo, et al.
Critical Care Medicine|October 1, 2021
Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical IllnessCarmen Mikacenic, Pavan Bhatraju, Cassianne Robinson-Cohen, et al.
CHEST Critical Care|October 18, 2024
Elevated Hemoglobin A1c and the Risk of Developing ARDS in Two Cohort StudiesAvery M Bogart, Christine R Lopez, Sarah N Obeidalla, et al.
Pediatric Blood & Cancer|June 1, 2024
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531Erin K Barr, Arlene Naranjo, Clare J Twist, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastomaAlexei L Polishchuk, Richard Li, Christine Hill-Kayser, et al.
Chest|November 6, 2022
Association Between Shared Decision-Making During Family Meetings and Surrogates' Trust in Their ICU PhysicianTaylor E Lincoln, Praewpannarai Buddadhumaruk, Robert M Arnold, et al.
Thorax|December 26, 2023
Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)Puja Mehta, Romit J Samanta, Katherine Wick, et al.
Pediatric Blood & Cancer|April 20, 2016
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk NeuroblastomaJudith G Villablanca, Samuel L Volchenboum, Hwangeui Cho, et al.
The Lancet. Respiratory Medicine|December 23, 2014
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trialJennifer G Wilson, Kathleen D Liu, Hanjing Zhuo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) TrialSteven G DuBois, Araz Marachelian, Elizabeth Fox, et al.
Pageof 134

Showing results (1191-1200 of 1,339) with videos related to

Sort By:
Pageof 134
Pediatric Blood & Cancer|April 7, 2017
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSteven G DuBois, Rajen Mody, Arlene Naranjo, et al.
Critical Care Medicine|October 1, 2021
Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical IllnessCarmen Mikacenic, Pavan Bhatraju, Cassianne Robinson-Cohen, et al.
CHEST Critical Care|October 18, 2024
Elevated Hemoglobin A1c and the Risk of Developing ARDS in Two Cohort StudiesAvery M Bogart, Christine R Lopez, Sarah N Obeidalla, et al.
Pediatric Blood & Cancer|June 1, 2024
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531Erin K Barr, Arlene Naranjo, Clare J Twist, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastomaAlexei L Polishchuk, Richard Li, Christine Hill-Kayser, et al.
Chest|November 6, 2022
Association Between Shared Decision-Making During Family Meetings and Surrogates' Trust in Their ICU PhysicianTaylor E Lincoln, Praewpannarai Buddadhumaruk, Robert M Arnold, et al.
Thorax|December 26, 2023
Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)Puja Mehta, Romit J Samanta, Katherine Wick, et al.
Pediatric Blood & Cancer|April 20, 2016
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk NeuroblastomaJudith G Villablanca, Samuel L Volchenboum, Hwangeui Cho, et al.
The Lancet. Respiratory Medicine|December 23, 2014
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trialJennifer G Wilson, Kathleen D Liu, Hanjing Zhuo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) TrialSteven G DuBois, Araz Marachelian, Elizabeth Fox, et al.
Pageof 134